Skip to content

Clinical trials

Endometrial Neoplasms trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Not applicable Country / region: United States Clear all

114 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20061
20071
20083
20093
20102
20127
20135
20147
20152
20163
20171
20189
20193
202011
202111
20225
20238
20247
20257
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Recruiting22
Active, not recruiting12
Terminated4
Unknown status4
Not yet recruiting3
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ohio State University Comprehensive Cancer Center7
Memorial Sloan Kettering Cancer Center6
Rutgers, The State University of New Jersey5
UNC Lineberger Comprehensive Cancer Center5
Case Comprehensive Cancer Center4
Northwestern University4
University of Wisconsin, Madison4
Duke University3
University of Alabama at Birmingham3
University of Utah3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms114
Uterine Cervical Neoplasms33
Ovarian Neoplasms31
Breast Neoplasms25
Prostatic Neoplasms16
Uterine Neoplasms11
Vulvar Neoplasms11
Neoplasms10
Colonic Neoplasms9
Colorectal Neoplasms9

Trials

Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.

14 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.